NIOX Group (NIOX) Competitors GBX 73.60 +0.20 (+0.27%) As of 11:53 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock NIOX vs. EKF, CREO, IUG, NCYT, IHC, POLX, AVO, SUN, RUA, and MHCShould you be buying NIOX Group stock or one of its competitors? The main competitors of NIOX Group include EKF Diagnostics (EKF), Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Inspiration Healthcare Group (IHC), Polarean Imaging (POLX), Advanced Oncotherapy (AVO), Surgical Innovations Group (SUN), RUA Life Sciences (RUA), and MyHealthChecked (MHC). These companies are all part of the "medical devices" industry. NIOX Group vs. Its Competitors EKF Diagnostics Creo Medical Group Intelligent Ultrasound Group Novacyt Inspiration Healthcare Group Polarean Imaging Advanced Oncotherapy Surgical Innovations Group RUA Life Sciences MyHealthChecked NIOX Group (LON:NIOX) and EKF Diagnostics (LON:EKF) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, media sentiment and institutional ownership. Is NIOX or EKF more profitable? NIOX Group has a net margin of 28.21% compared to EKF Diagnostics' net margin of 9.37%. NIOX Group's return on equity of 13.29% beat EKF Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets NIOX Group28.21% 13.29% 3.95% EKF Diagnostics 9.37%7.03%5.27% Do institutionals and insiders hold more shares of NIOX or EKF? 7.6% of NIOX Group shares are held by institutional investors. Comparatively, 50.0% of EKF Diagnostics shares are held by institutional investors. 4.9% of NIOX Group shares are held by insiders. Comparatively, 39.4% of EKF Diagnostics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has preferable valuation and earnings, NIOX or EKF? NIOX Group has higher earnings, but lower revenue than EKF Diagnostics. EKF Diagnostics is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNIOX Group£41.80M7.36£995.88M£0.018,867.47EKF Diagnostics£50.19M2.68£4.68M£0.012,173.91 Which has more volatility & risk, NIOX or EKF? NIOX Group has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Comparatively, EKF Diagnostics has a beta of 0.57, meaning that its share price is 43% less volatile than the S&P 500. Does the media refer more to NIOX or EKF? In the previous week, EKF Diagnostics had 2 more articles in the media than NIOX Group. MarketBeat recorded 4 mentions for EKF Diagnostics and 2 mentions for NIOX Group. EKF Diagnostics' average media sentiment score of 0.88 beat NIOX Group's score of 0.37 indicating that EKF Diagnostics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NIOX Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral EKF Diagnostics 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend NIOX or EKF? NIOX Group currently has a consensus target price of GBX 90, suggesting a potential upside of 22.28%. Given NIOX Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe NIOX Group is more favorable than EKF Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NIOX Group 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00EKF Diagnostics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryNIOX Group beats EKF Diagnostics on 9 of the 16 factors compared between the two stocks. Get NIOX Group News Delivered to You Automatically Sign up to receive the latest news and ratings for NIOX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NIOX vs. The Competition Export to ExcelMetricNIOX GroupMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£307.52M£2.55B£5.76B£2.57BDividend Yield1.76%2.45%5.74%5.31%P/E Ratio8,867.47263.4576.555,395.57Price / Sales7.36149.44495.3997,515.32Price / Cash11.2115.9937.1727.93Price / Book4.083.7913.729.20Net Income£995.88M£132.05M£3.29B£5.89B7 Day Performance3.66%1.90%1.03%0.74%1 Month Performance5.44%-1.58%6.32%3.37%1 Year Performance12.88%15.94%81.16%190.45% NIOX Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NIOXNIOX Group1.7515 of 5 starsGBX 73.60+0.3%GBX 90+22.3%+11.6%£307.52M£41.80M8,867.4792News CoverageEKFEKF DiagnosticsN/AGBX 29-2.0%N/A+6.0%£130.24M£50.19M2,101.45356Earnings ReportCREOCreo Medical GroupN/AGBX 12.50-1.0%N/A-62.7%£51.56M£4M-156.25279High Trading VolumeIUGIntelligent Ultrasound GroupN/AN/AN/AN/A£42.76M£6.57M-18.9165NCYTNovacytN/AGBX 40-0.1%N/A-45.4%£28.25M£19.63M-67.80120IHCInspiration Healthcare GroupN/AGBX 21.08-2.0%N/A-4.4%£18.90M£38.25M-111.99224Gap DownPOLXPolarean ImagingN/AGBX 0.80-8.6%N/A-58.7%£9.66M£3.09M-72.7328Gap DownHigh Trading VolumeAVOAdvanced OncotherapyN/AN/AN/AN/A£9.50MN/A-25.003,900Gap DownSUNSurgical Innovations GroupN/AGBX 0.73+4.4%N/A+12.3%£6.82M£11.95M-348.1080Gap UpRUARUA Life SciencesN/AGBX 10.51-4.5%N/A-2.5%£6.52M£4.11M-2.6148MHCMyHealthCheckedN/AGBX 10.25-2.4%N/A-20.8%£5.33M£3.61M-297.1016Gap Down Related Companies and Tools Related Companies EKF Diagnostics Alternatives Creo Medical Group Alternatives Intelligent Ultrasound Group Alternatives Novacyt Alternatives Inspiration Healthcare Group Alternatives Polarean Imaging Alternatives Advanced Oncotherapy Alternatives Surgical Innovations Group Alternatives RUA Life Sciences Alternatives MyHealthChecked Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:NIOX) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NIOX Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share NIOX Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NIOX Stock Alerts